China Wholesale PLIF PEEK Cages Manufacturers & Exporters

Macro Spinal Fusion Industry & Clinical Solutions

In modern spinal arthrodesis, Posterior Lumbar Interbody Fusion (PLIF) remains a primary approach for correcting mechanical instability, spinal stenosis, and degenerative disc diseases (DDD). The clinical success of interbody fusion depends directly on the biological and structural stability of the chosen implant. Historically, implants transitioned from autologous bone grafts to titanium alloys, and subsequently to medical-grade Polyetheretherketone (PEEK) polymers.

From a clinical biomechanical perspective, titanium alloy implants exhibit an elastic modulus (approximately 110 GPa) that is significantly higher than that of human cortical bone (typically 12 to 18 GPa). This severe modulus mismatch introduces stress shielding, a phenomenon where the metal cage bears the majority of the physiological load. Consequently, the adjacent vertebral bone experiences reduced mechanical stimulation, leading to localized osteoclast activity and an elevated risk of implant subsidence or non-union.

To address this clinical limitation, PEEK-OPTIMA™ and similar implant-grade polymers have become the standard biomaterial. With an elastic modulus of approximately 3.6 GPa, PEEK mimics the natural mechanical properties of cortical bone. This ensures a balanced load transfer across the interbody space, stimulating natural osteogenesis (according to Wolff’s Law) while preserving structural integrity. Furthermore, PEEK is completely radiolucent. Unlike titanium, which produces severe scatter and artifacts on X-ray, CT, and MRI scans, PEEK cages allow surgeons to evaluate post-operative fusion progress, bone growth, and density through clear visual verification.

Company Profile

Axiora Medical Technology (China) Co., Ltd. is a professional manufacturer specializing in the research, development, production, and global supply of high-quality orthopedic implants and surgical instruments. Our product portfolio covers trauma fixation systems, spinal implants, joint reconstruction solutions, sports medicine products, and related orthopedic surgical instruments.

Established with a commitment to innovation and precision manufacturing, Axiora integrates advanced CNC machining, automated production lines, and strict quality management systems to deliver reliable products that meet international standards. Our experienced engineering team continuously develops innovative solutions to support surgeons and healthcare providers worldwide.

With strong OEM and ODM capabilities, we provide customized manufacturing services according to customers' drawings, samples, and technical requirements. From product design and prototyping to mass production and packaging, our integrated manufacturing process ensures consistent quality, competitive pricing, and on-time delivery.

Today, Axiora exports its orthopedic products to customers across Europe, North America, South America, the Middle East, Southeast Asia, and Africa, building long-term partnerships with medical device distributors, brand owners, hospitals, and healthcare organizations around the world.

Global Regulatory Compliance & Materials Sourcing

In medical manufacturing, material integrity is paramount. Axiora sources only implant-grade PEEK polymer (such as Evonik VESTAKEEP® or Solvay Zeniva®) from qualified suppliers. Every shipment includes a certified Certificate of Conformity (CoC) and batch-specific chemical composition records, establishing full transparency from raw stock to finished sterile packaging.

Our quality management system is certified under ISO 13485:2016, the international standard for medical device quality management. We maintain complete product history records (DHR) for all manufactured implants. To satisfy the regulatory requirements of importing countries (including FDA pathways and EU CE Mark directives), our implants undergo comprehensive mechanical evaluation in accordance with ASTM standards:

• ASTM F2077: Compressive, shear, and torsion fatigue testing to evaluate structural stability under physiological loading.
• ASTM F2267: Subsidence testing under axial load to quantify resistance to vertebral endplate penetration.
• ISO 10993: Biological safety evaluations, including cytotoxicity, systemic toxicity, and genotoxicity, to verify biocompatibility.

For wholesale importers and distributors, we offer detailed regulatory support, providing complete technical documentation, raw material testing reports, and ISO certificates to facilitate the registration process with local health authorities.

Spinal Implant R&D & Future Outlook

To optimize osseointegration, modern implant manufacturing has advanced beyond standard smooth PEEK profiles. Axiora's R&D team is currently developing and validating two key technologies:

1. Porous Titanium-Coated PEEK (Ti-PEEK): This composite design combines the low modulus of elasticity of PEEK with the bioactive properties of titanium. Using physical vapor deposition (PVD) or plasma spraying, we apply a micro-porous titanium layer to the PEEK substrate. This encourages early cellular attachment and bone integration, while the underlying PEEK core prevents stress shielding.

2. 3D-Printed Porous Architectures: Through additive manufacturing (3D printing PEEK using FFF/FDM technology), we are working to produce biomimetic, interconnected pore networks. These structures simulate trabecular bone, allowing vascularization and cell migration directly through the implant body to accelerate fusion.